Prokineticin signaling is required for the maintenance of a de novo population of c-KIT+ cells to sustain neuroblastoma progression

Oncogene

Volumn 34, Issue 8, 2015, Pages 1019-1034

  Lau, S T ^a   Hansford, L M ^b   Chan, W K ^c   Chan, G C F ^c   Wan, T S K ^c   Wong, K K Y ^a   Kaplan, D R ^b   Tam, P K H ^a,c   Ngan, E S W ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84944964371     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.24     Document Type: Article

References (33)

1. Coulon A, Flahaut M, Muhlethaler-Mottet A, Meier R, Liberman J, Balmas-Bourloud K et al. Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model. Neoplasia 2011; 13: 991-1004.
2. Hansford LM, McKee AE, Zhang L, George RE, Gerstle JT, Thorner PS et al. Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell. Cancer Res 2007; 67: 11234-11243.
3. Hutt KJ, McLaughlin EA, Holland MK. Kit ligand and c-Kit have diverse roles during mammalian oogenesis and folliculogenesis. Mol Hum Reprod 2006; 12: 61-69.
4. Lacham-Kaplan O. In vivo and in vitro differentiation of male germ cells in the mouse. Reproduction 2004; 128: 147-152.
5. Luo R, Gao J, Wehrle-Haller B, Henion PD. Molecular identification of distinct neurogenic and melanogenic neural crest sublineages. Development 2003; 130: 321-330.
6. Vitali R, Cesi V, Nicotra MR, McDowell HP, Donfrancesco A, Mannarino O et al. c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571. Int J Cancer 2003; 106: 147-152.
7. Chen QR, Song YK, Wei JS, Bilke S, Asgharzadeh S, Seeger RC et al. An integrated cross-platform prognosis study on neuroblastoma patients. Genomics 2008; 92: 195-203.
8. Liegl-Atzwanger B, Fletcher JA, Fletcher CD. Gastrointestinal stromal tumors. Virchows Arch 2010; 456: 111-127.
9. Krams M, Parwaresch R, Sipos B, Heidorn K, Harms D, Rudolph P. Expression of the c-kit receptor characterizes a subset of neuroblastomas with favorable prognosis. Oncogene 2004; 23: 588-595.
10. LeCouter J, Kowalski J, Foster J, Hass P, Zhang ZM, Dillard-Telm L et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001; 412: 877-884.
11. Shimada A, Hirato J, Kuroiwa M, Kikuchi A, Hanada R, Wakai K et al. Expression of KIT and PDGFR is associated with a good prognosis in neuroblastoma. Pediatr Blood Cancer 2008; 50: 213-217.
12. Thiele CJ. Neuroblastoma cell lines. In: Masters J (eds). Human Cell Culture, vol. 1. Kluwer Academic Publishers: Lancaster, 1998, pp 21-53.
13. Uccini S, Mannarino O, McDowell HP, Pauser U, Vitali R, Natali PG et al. Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors. Clin Cancer Res 2005; 11: 380-389.
14. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U et al. A distinct 'side population' of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 2004; 101: 14228-14233.
15. Biagiotti T, D'Amico M, Marzi I, Di Gennaro P, Arcangeli A, Wanke E et al. Cell renewing in neuroblastoma: electrophysiological and immunocytochemical characterization of stem cells and derivatives. Stem Cells (Dayton, OH) 2006; 24: 443-453.
16. Marzi I, D'Amico M, Biagiotti T, Giunti S, Carbone MV, Fredducci D et al. Purging of the neuroblastoma stem cell compartment and tumor regression on exposure to hypoxia or cytotoxic treatment. Cancer Res 2007; 67: 2402-2407.
17. Nilsson MB, Zage PE, Zeng L, Xu L, Cascone T, Wu HK et al. Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors. Oncogene 2010; 29: 2938-2949.
18. Jogi A, Ora I, Nilsson H, Lindeheim A, Makino Y, Poellinger L et al. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA 2002; 99: 7021-7026.
19. Ngan ES, Sit FY, Lee K, Miao X, Yuan Z, Wang W et al. Implications of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 signaling in human neuroblastoma progression. Clin Cancer Res 2007; 13: 868-875.
20. Pietras A, Gisselsson D, Ora I, Noguera R, Beckman S, Navarro S et al. High levels of HIF-2alpha highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche. J Pathol 2008; 214: 482-488.
21. Cohen PS, Chan JP, Lipkunskaya M, Biedler JL, Seeger RC. Expression of stem cell factor and c-kit in human neuroblastoma. The Children's Cancer Group. Blood 1994; 84: 3465-3472.
22. Asgharzadeh S, Pique-Regi R, Sposto R, Wang H, Yang Y, Shimada H et al. Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification. J Natl Cancer Inst 2006; 98: 1193-1203.
23. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H et al. Distinct sets of genetic alterations in melanoma. New Engl J Med 2005; 353: 2135-2147.
24. Gomes AL, Reis-Filho JS, Lopes JM, Martinho O, Lambros MB, Martins A et al. Molecular alterations of KIT oncogene in gliomas. Cell Oncol 2007; 29: 399-408.
25. Bellone G, Smirne C, Carbone A, Buffolino A, Scirelli T, Prati A et al. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes. Int J Oncol 2006; 29: 851-859.
26. Krystal GW, Hines SJ, Organ CP. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor. Cancer Res 1996; 56: 370-376.
27. Pietras A, Hansford LM, Johnsson AS, Bridges E, Sjolund J, Gisselsson D et al. HIF-2alpha maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells. Proc Natl Acad Sci USA 2009; 106: 16805-16810.
28. Pittoni P, Piconese S, Tripodo C, Colombo MP. Tumor-intrinsic and-extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors. Oncogene 2011; 30: 757-769.
29. Perez-Losada J, Sanchez-Martin M, Rodriguez-Garcia A, Sanchez ML, Orfao A, Flores T et al. Zinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathway. Blood 2002; 100: 1274-1286.
30. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
31. Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, Kuperwasser C, Lander ES et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011; 146: 633-644.
32. Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, Spitz R et al. Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification. J Clin Oncol 2006; 24: 5070-5078.
33. Walton JD, Kattan DR, Thomas SK, Spengler BA, Guo HF, Biedler JL et al. Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia 2004; 6: 838-845.